Figure 2.
Figure 2. Trial profile. *Desogestrel-containing OCs, 30 μg ethinylestradiol + 150 μg desogestrel; levonorgestrel-containing OCs, 30 μg ethinylestradiol + 150 μg levonor gestrel; desogestrel only, 150 μg desogestrel; and levonorgestrel only, 150 μg levonorgestrel. X indicates blood sampling. → indicates comparisons described in the tables. Comparisons referring to Tables 2-3 are also made for women with the factor VLeiden mutation.

Trial profile.*Desogestrel-containing OCs, 30 μg ethinylestradiol + 150 μg desogestrel; levonorgestrel-containing OCs, 30 μg ethinylestradiol + 150 μg levonor gestrel; desogestrel only, 150 μg desogestrel; and levonorgestrel only, 150 μg levonorgestrel. X indicates blood sampling. → indicates comparisons described in the tables. Comparisons referring to Tables 2-3 are also made for women with the factor VLeiden mutation.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal